Blue Heron
On sale on the US market (according to the DSLD)
Integrative Therapeutics, food supplement from the US market
Blue Heron (Integrative Therapeutics), a food supplement au code-barres 871791000636, is described by its US market label. If sold in France, it would be subject to 2 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Integrative Therapeutics
- Barcode
- 871791000636
- Form
- Capsule
- One serving
- 6 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Hypromellose, Calcium Laurate, Cellulose
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Calories | Other | 10 Calorie(s) |
| Total Carbohydrates | Carbohydrate | 2 Gram(s) |
| Dietary Fiber | Fibre | 1 Gram(s) |
| Flax (Linum usitatissimum) | Plant | 1.2 Gram(s) |
| Rice (Oryza sativa) bran | Fibre | 1.2 Gram(s) |
| Psyllium | Fibre | 200 mg |
| Plum (Prunus domestica) | Plant | 180 mg |
| Fenugreek (Trigonella foenum-graecum) | Plant | 150 mg |
| Slippery Elm (Ulmus rubra) | Plant | 150 mg |
| Triphala Extract Blend | Blend | 150 mg |
| Spectra Probiotic Proprietary Blend | Blend | 60 mg |
| Lactobacillus acidophilus | Micro-organism | not stated |
| Bifidobacterium bifidum | Micro-organism | not stated |
| Bifidobacterium infantis | Micro-organism | not stated |
| Bifidobacterium longum | Micro-organism | not stated |
| Lactobacillus casei | Micro-organism | not stated |
| Lactobacillus helveticus | Micro-organism | not stated |
| Lactobacillus salivarius | Micro-organism | not stated |
| Streptococcus thermophilus | Micro-organism | not stated |
| Marshmallow (Althaea officinalis) root extract (Althaea officinalis) | Plant | 48 mg |
| Papain | Enzyme | 3.7 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Blue Heron
Entered into DSLD on 24 July 2019. Withdrawn from the US market on 4 April 2022 (according to the DSLD).Same active composition.
Official label: Blue Heron
Entered into DSLD on 24 July 2019. Withdrawn from the US market on 2 January 2019 (according to the DSLD).- Active ingredient removed : Calories (10 Calorie(s))
Official label: Blue Heron
Entered into DSLD on 25 January 2018. Withdrawn from the US market on 3 December 2018 (according to the DSLD).- Active ingredient added : Amla (quantity not stated)
- Active ingredient added : Belleric Myrobalan (quantity not stated)
- Active ingredient added : DELETE (150 mg)
- Active ingredient added : Triphala Blend (150 mg)
- Active ingredient added : tropical Almond (quantity not stated)
- Active ingredient removed : Slippery Elm (150 mg)
- Active ingredient removed : Triphala Extract Blend (150 mg)
- Quantity stated differently, without estimation : Dietary Fiber: < 1 Gram(s) in this version; 1 Gram(s) on the displayed label
Official label: Blue Heron
Entered into DSLD on 25 July 2013. Withdrawn from the US market on 21 June 2017 (according to the DSLD).- Active ingredient added : Protein (< 1 g)
- Active ingredient removed : Bifidobacterium bifidum (quantity not stated)
- Active ingredient removed : Bifidobacterium infantis (quantity not stated)
- Active ingredient removed : Bifidobacterium longum (quantity not stated)
- Active ingredient removed : Lactobacillus acidophilus (quantity not stated)
- Active ingredient removed : Lactobacillus casei (quantity not stated)
- Active ingredient removed : Lactobacillus helveticus (quantity not stated)
- Active ingredient removed : Lactobacillus salivarius (quantity not stated)
- Active ingredient removed : Streptococcus thermophilus (quantity not stated)
- Same quantity, different name: Dried Plum in this version; Plum on the displayed label (180 mg)
- Same quantity, different name: Triphala in this version; Triphala Extract Blend on the displayed label (150 mg)
- Different unit, without conversion : Calories: 20 {Calories} in this version; 10 Calorie(s) on the displayed label
- Different unit, without conversion : Dietary Fiber: 2 g in this version; 1 Gram(s) on the displayed label
- Different unit, without conversion : Flax: 12 g in this version; 1.2 Gram(s) on the displayed label
- Different unit, without conversion : Psyllium: 12 g in this version; 200 mg on the displayed label
- Different unit, without conversion : Rice (Oryza sativa) bran: 12 g in this version; 1.2 Gram(s) on the displayed label
- Different unit, without conversion : Total Carbohydrates: 3 g in this version; 2 Gram(s) on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Flax
Read the warning, when it applies and the studies cited
FLAXSEED - LINUM USITATISSIMUM
Route of administration: Oral
Cautions and warnings
Applies to products providing 5 g or more of flaxseed per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).
Sources cited by Health Canada (1)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).
Sources cited by Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
Condition of application: Laxative; Promotion of bowel movement; Constipation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).
Sources cited by Health Canada (2)
- Pray WS. 2006. Non-Prescription Product Therapeutics, 2nd edition. New York (NY): Lippincott Williams & Wilkins.
- Repchinsky 2002: Canadian Pharmacists Association. Patient Self-Care. Helping Patients Make Therapeutic Choices. Ottawa (ON): Canadian Pharmacists Association.
Contraindications
Applies to products providing 5 g or more of flaxseed per day.
Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).
Sources cited by Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).
Sources cited by Health Canada (4)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
- Gardner Z. and McGuffin M. editors. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. American Herbal Products Association. Boca Raton (FL): CRC Press; 2013.
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).
Sources cited by Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- León F, Rodríguez M, Cuevas M. 2003. Anaphylaxis to Linum. Allergologia et immunopathologia 31(1):47-49.
- Fenugreek
Read the warning, when it applies and the studies cited
FENUGREEK - TRIGONELLA FOENUM-GRAECUM - Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Gardner and McGuffin 2013; Brinker 2010; Mills et al. 2006; Hoffman 2003; Blumenthal et al. 2000).
Sources cited by Health Canada (4)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
- Mills E, Duguoa J, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation. An Evidence-Based Approach. New York (NY): Taylor and Francis; 2006.
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Health Canada monograph dated 29 May 2026
FENUGREEK - TRIGONELLA FOENUM-GRAECUM - Topical
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Marshmallow (Althaea officinalis) root extract
Read the warning, when it applies and the studies cited
Marshmallow - ALTHAEA OFFICINALIS - Root
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Health Canada monograph dated 19 December 2025
MARSHMALLOW - ALTHAEA OFFICINALIS - LEAF
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Integrative Therapeutics
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Blue Heron (Integrative Therapeutics): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/871791000636-blue-heron-integrative-therapeutics, updated 18 July 2023.